source
- Siemens Healthineers partners with Novo to raise awareness and testing for fatty liver diseaseSiemens Healthineers and Novo have announced a collaboration aimed at increasing awareness and improving diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progre…
- Cordis receives FDA approval for first sirolimus drug-coated balloon for coronary in-stent restenosisThe U.S. Food and Drug Administration has approved a new device from Cordis that delivers sirolimus via a drug-coated balloon. This is the first sirolimus-eluting balloon cleared for use in treatin…